Warby Parker (WRBY) Cash from Financing Activities (2020 - 2026)
Warby Parker's (WRBY) quarterly Cash from Financing Activities came in at -$6.2 million in Q1 2026, down 167.59% YoY from $9.1 million in Q1 2025, and down 166.21% on a QoQ basis from -$2.3 million in Q4 2025.
Warby Parker (WRBY) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Cash from Financing Activities data on file, last reported at -$6.2 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 167.59% year-over-year to -$6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.9 million (down 717.89% YoY) and the FY2025 annual result came in at -$12.0 million, down 341.92% from the prior year.
- Cash from Financing Activities fell to -$6.2 million in Q1 2026, from -$2.3 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $3.6 million in Q2 2024 to a low of -$6.2 million in Q1 2026.
- A 5-year average of -$413882.4 and a median of $112000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 108.45% — and 2025, when it slumped 9904.26%.
- Tracing WRBY's Cash from Financing Activities over 5 years: stood at $1.2 million in 2022, then plunged by 39.01% to $730000.0 in 2023, then soared by 65.07% to $1.2 million in 2024, then slumped by 292.03% to -$2.3 million in 2025, then tumbled by 166.21% to -$6.2 million in 2026.
- The last three Cash from Financing Activities figures came in at -$6.2 million (Q1 2026), -$2.3 million (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | -2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.30 Mn |
| Jun 30, 2026 | -2.30 Mn |
| Mar 31, 2026 | -6.16 Mn |
| Mar 31, 2026 | -6.16 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Sep 30, 2025 | -4.61 Mn |
| Sep 30, 2025 | -4.61 Mn |
| Jun 30, 2025 | -2.77 Mn |
| Jun 30, 2025 | -2.77 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 47,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | 91,000.00 |
| Mar 31, 2024 | 91,000.00 |